Skip to content

SURGICAL & PODOLOGY INSTRUMENTS: what changed

BE 0473.474.519NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€1,265
2024 · €10,605-€9,341
Equity
€92,036
2024 · €140,772-€48,735
Cash
€54,386
2024 · €79,792-€25,406
Balance sheet total
€138,360
2024 · €156,938-€18,579

Largest movements

2024 to 2025
Assets
  • Cash -€25,406

    down €25,406 (-31.8%), from €79,792 to €54,386

    mainly Contributions, distributions and other (-€50,000) and Stocks and contracts (-€7,630)

  • Stocks and contracts +€7,630

    up €7,630 (+18.4%), from €41,365 to €48,995

  • Receivables within one year -€6,151

    down €6,151 (-19.5%), from €31,504 to €25,353

    of which Trade receivables: -€8,602

  • Intangible fixed assets +€5,385

    new in 2025: €5,385

Equity and liabilities
  • Profit (loss) carried forward -€48,140

    down €48,140 (-62.7%), from €76,786 to €28,646

  • Other debts +€29,213

    up €29,213 (+281%), from €10,386 to €39,599

Income statement
  • Gross operating margin -€11,518

    down €11,518 (-68.0%), from €16,932 to €5,413

  • Taxes -€3,606

    down €3,606 (-74.0%), from €4,874 to €1,268

  • Other operating charges +€816

    up €816 (+221%), from €368 to €1,184

  • Depreciation +€306

    new in 2025: €306

  • Financial charges +€224

    up €224 (+19.0%), from €1,177 to €1,401

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €10,605
Gross operating margin -€11,518
Depreciation -€306
Other operating charges -€816
Financial income -€84
Financial charges -€224
Taxes +€3,606
Result 2025 €1,265
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€30,285
Investment -€5,691
Financing -€50,000
Cash 2024 €79,792
Net result for the year +€1,265
Depreciation +€306
Stocks and contracts -€7,630
Receivables within one year +€6,151
Deferred charges and accrued income +€37
Trade debts +€944
Other debts +€29,213
Investment in fixed assets (net) -€5,691
Contributions, distributions and other -€50,000
Cash 2025 €54,386
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €156,938 €138,360 -€18,579 -11.8%
Fixed assets 21/28 €1,785 €7,170 +€5,385 +302%
Intangible fixed assets 21 - €5,385 +€5,385
Financial fixed assets 28 €1,785 €1,785 = 0.0%
Current assets 29/58 €155,153 €131,190 -€23,964 -15.4%
Stocks and contracts in progress 3 €41,365 €48,995 +€7,630 +18.4%
Stocks 30/36 €41,365 €48,995 +€7,630 +18.4%
Amounts receivable within one year 40/41 €31,504 €25,353 -€6,151 -19.5%
Trade receivables 40 €20,249 €11,647 -€8,602 -42.5%
Other amounts receivable 41 €11,255 €13,705 +€2,451 +21.8%
Cash at bank and in hand 54/58 €79,792 €54,386 -€25,406 -31.8%
Deferred charges and accrued income 490/1 €2,492 €2,455 -€37 -1.5%
Total equity and liabilities 10/49 €156,938 €138,360 -€18,579 -11.8%
Equity 10/15 €140,772 €92,036 -€48,735 -34.6%
Contributions 10/11 €6,197 €6,197 = 0.0%
Reserves 13 €57,788 €57,193 -€595 -1.0%
Distributable reserves 133 €57,788 €57,193 -€595 -1.0%
Profit (loss) carried forward 14 €76,786 €28,646 -€48,140 -62.7%
Amounts payable 17/49 €16,166 €46,323 +€30,157 +187%
Amounts payable within one year 42/48 €16,166 €46,323 +€30,157 +187%
Trade debts 44 €5,742 €6,687 +€944 +16.4%
Suppliers 440/4 €5,742 €6,687 +€944 +16.4%
Taxes, remuneration and social security 45 €37 €37 = 0.0%
Taxes 450/3 €37 €37 = 0.0%
Other amounts payable 47/48 €10,386 €39,599 +€29,213 +281%
Non-recurring operating income 76A €83 - -€83
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 - €306 +€306
Other operating charges 640/8 €368 €1,184 +€816 +221%
Gross operating margin 9900 €16,932 €5,413 -€11,518 -68.0%
Operating profit (loss) 9901 €16,563 €3,924 -€12,639 -76.3%
Financial income 75/76B €94 €10 -€84 -89.2%
Recurring financial income 75 €94 €10 -€84 -89.2%
Financial charges 65/66B €1,177 €1,401 +€224 +19.0%
Recurring financial charges 65 €1,177 €1,401 +€224 +19.0%
Profit (loss) for the period before taxes 9903 €15,479 €2,533 -€12,947 -83.6%
Income taxes 67/77 €4,874 €1,268 -€3,606 -74.0%
Profit (loss) for the period 9904 €10,605 €1,265 -€9,341 -88.1%
Profit (loss) for the period to be appropriated 9905 €10,605 €1,265 -€9,341 -88.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€79,151 to €93,481

Midpoint €85,122 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €86,651
Capitalised earnings €71,650 to €100,310
Indication €79,151 to €93,481

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€92,036
Intangible fixed assets (21)
-€5,385
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€86,651

Capitalised earnings

net result for the year (9904)
2025
€1,265
2024
€10,605
excluding non-recurring income and charges
€10,522
2023
€15,313
excluding non-recurring income and charges
€18,308
2022
€12,916
2021
€7,094
Average result, excluding non-recurring income and charges
€10,031
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€71,650 / €83,592 / €100,310

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 12 November 2026 via checked.be.